Rhön-Klinikum AG Stock
Your prediction
Pros and Cons of Rhön-Klinikum AG in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Rhön-Klinikum AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Rhön-Klinikum AG | 1.370% | -2.013% | 11.450% | 26.957% | 14.961% | 22.689% | -7.712% |
| Molina Healthcare | 2.050% | 1.770% | -10.990% | 22.451% | 20.103% | -38.474% | -21.085% |
| Chemed Corp. | -0.890% | -4.622% | 6.573% | 19.474% | 24.725% | - | - |
| Davita Inc. | 0.620% | -4.147% | -26.375% | 31.793% | 58.181% | 64.776% | 34.702% |
Comments
News
EQS-Adhoc: Asklepios Kliniken GmbH & Co. KGaA submits request for the implementation of a squeeze-out of the minority shareholders of RHÖN-Klinikum Aktiengesellschaft
EQS-Adhoc: Asklepios Kliniken GmbH & Co. KGaA submits request for the implementation of a squeeze-out of the minority shareholders of RHÖN-Klinikum Aktiengesellschaft
EQS-News: RHÖN-KLINIKUM AG continues stable trend in first half of 2026
EQS-News: RHÖN-KLINIKUM AG continues stable trend in first half of 2026
EQS-News: RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
EQS-News: RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026